Wokeism Killing People

[Toro]

Wokeism is a disease. And it’s killing people.

In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.​

Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions. Sibarium’s reporting in the Free Beacon spread to various right-wing media outlets, prompting significant pushback. Under threat of legal action, SSM Health announced on January 14 that it “no longer” uses race criteria. On January 11, Minnesota’s public-health authorities edited out the BIPOC reference, leaving no trace of the previous wording. New York State, however, has not yet altered its guidelines.​

Race-Based Rationing Is Real—And Dangerous

The cultural left’s worldview is beginning to distort health policy.

www.theatlantic.com

Awful awful awful ideology.

 

[Not a Monkeys Uncle]

Wokeism is LITERALLY killing people

 

[Harry Dresden]

its part of the "uniters" plan.....

 

[Mac1958]

PC/Identity Politics have always been a rotten idea.

 

[BrokeLoser]

PC/Identity Politics have always been a rotten idea.

But, but, but….Orange man’s tweets and what they do to your FEELZ is far worse…right?

 

[Doc7505]

PC/Identity Politics have always been a rotten idea.

I'm sure that Whoopie Goldberg will now agree with you.

 

[Missourian]

Wokeism is a disease. And it’s killing people.

In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.​

Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions. Sibarium’s reporting in the Free Beacon spread to various right-wing media outlets, prompting significant pushback. Under threat of legal action, SSM Health announced on January 14 that it “no longer” uses race criteria. On January 11, Minnesota’s public-health authorities edited out the BIPOC reference, leaving no trace of the previous wording. New York State, however, has not yet altered its guidelines.​

Race-Based Rationing Is Real—And Dangerous

The cultural left’s worldview is beginning to distort health policy.

www.theatlantic.com

Awful awful awful ideology.

This policy came straight from that dipshit you voted for...

Biden administration guidance prioritizes race in administering COVID drugs

Guidance issued under the Biden administration states certain individuals may be considered “high risk” and more quickly qualify for monoclonal antibodies and oral antivirals used to treat COVID-19 based on their “race or ethnicity.”

news.yahoo.com

 

[OKTexas]

Wokeism is a disease. And it’s killing people.

In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.​

Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions. Sibarium’s reporting in the Free Beacon spread to various right-wing media outlets, prompting significant pushback. Under threat of legal action, SSM Health announced on January 14 that it “no longer” uses race criteria. On January 11, Minnesota’s public-health authorities edited out the BIPOC reference, leaving no trace of the previous wording. New York State, however, has not yet altered its guidelines.​

Race-Based Rationing Is Real—And Dangerous

The cultural left’s worldview is beginning to distort health policy.

www.theatlantic.com

Awful awful awful ideology.

Didn't the FDA withdraw emergency use authorization for monoclonal antibodies?

.

 

[CowboyTed]

Surprise Surprise...

This turns out to be over blown bullshit...

Trump on 'Race-Based Medicine' for COVID-19 - FactCheck.org

At a rally in Arizona on Jan. 15, former President Donald Trump waded into the debate over state policies allowing health systems to consider race as a risk factor when prioritizing the allocation of limited supplies of some COVID-19 therapeutics. According to Trump, it translates to white...

www.factcheck.org

There is a policy on race but that is based on science...

By the way is was the Trump Administration that came up with this:

Coronavirus Disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.

web.archive.org

Opps... So Trump came up with all this... A lot of guys here are going to have a come to Jesus moment and change views...

 

[IM2]

Wokeism is a disease. And it’s killing people.

In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.​

Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions. Sibarium’s reporting in the Free Beacon spread to various right-wing media outlets, prompting significant pushback. Under threat of legal action, SSM Health announced on January 14 that it “no longer” uses race criteria. On January 11, Minnesota’s public-health authorities edited out the BIPOC reference, leaving no trace of the previous wording. New York State, however, has not yet altered its guidelines.​

Race-Based Rationing Is Real—And Dangerous

The cultural left’s worldview is beginning to distort health policy.

www.theatlantic.com

Awful awful awful ideology.

Bullshit.

 

[22lcidw]

Bullshit.

Many of the Prog politicians do not believe what they spew. They would be total despots in a much more authoritarian environment. It is about power and money. and they will screw over their own for it. there are African Americans who are of the same way.

 

[frigidweirdo]

Wokeism is a disease. And it’s killing people.

In a series of articles this month, The Washington Free Beacon’s Aaron Sibarium reported that hospitals in Minnesota, Utah, New York, Illinois, Missouri, and Wisconsin have been using race as a factor in which COVID-19 patients receive scarce monoclonal-antibody treatments first. Last year, SSM Health, a network of 23 hospitals, began using a points system to ration access to Regeneron. The drug would be given to patients only if they netted 20 points or higher. Being “non-White or Hispanic” counted for seven points, while obesity got you only one point—even though, according to the CDC, “obesity may triple the risk of hospitalization due to a COVID-19 infection.” Based on this scoring system, a 40-year-old Hispanic male in perfect health would receive priority over an obese, diabetic 40-year-old white woman with asthma and hypertension.​

Meanwhile, Minnesota’s Department of Health used a scoring calculator that counted “BIPOC status” as equivalent to being 65 years and older in its risk assessment. (BIPOC is shorthand for Black, Indigenous, and people of color.) New York did away with a points system entirely; people of color are automatically deemed to be at elevated risk of harm from COVID—and therefore are given higher priority for therapeutics—irrespective of their underlying health conditions. Sibarium’s reporting in the Free Beacon spread to various right-wing media outlets, prompting significant pushback. Under threat of legal action, SSM Health announced on January 14 that it “no longer” uses race criteria. On January 11, Minnesota’s public-health authorities edited out the BIPOC reference, leaving no trace of the previous wording. New York State, however, has not yet altered its guidelines.​

Race-Based Rationing Is Real—And Dangerous

The cultural left’s worldview is beginning to distort health policy.

www.theatlantic.com

Awful awful awful ideology.

That's not being woke. Whatever it is, it's not "woke"

 

[Rigby5]

Didn't the FDA withdraw emergency use authorization for monoclonal antibodies?

.

No, monoclonal antibodies are the most successful means of treatment.
{...
According to the Food and Drug Administration (FDA)Trusted Source, this experimental treatment uses “laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses” like SARS-CoV-2.
It’s especially useful for people with weakened immune systems who may not generate a robust response to the COVID-19 vaccines, and for others at high risk of severe illness.
While monoclonal antibodies can start to clear the coronavirus within hours of being infused intravenously (IV) into the body, this treatment may not work for everyone.
That’s why experts recommend that people get fully vaccinated against COVID-19, which is known to prevent severe illness and hospitalization due to the disease.

How do monoclonal antibodies work?​

A monoclonal antibody is a laboratory-produced protein that functions like the antibodies made by the immune system in response to infection.
By binding to a specific molecule on a virus or bacteria — known as an antigen — a monoclonal antibody can enhance or restore the immune response against these pathogens.
Monoclonal antibody treatment has been used and testedTrusted Source for the Ebola virus and respiratory syncytial virus (RSV), as well as chronic illnesses such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and more.
Scientists are also developing monoclonal antibodies that target cancer cells.
Scientists sometimes develop monoclonal antibodies by isolating certain immune cells — called B cells — from a person who has successfully recovered from an infection.
With COVID-19, “we looked in people who had a good antibody response to the virus and picked out the very best antibodies that they made,” said Robert Carnahan, PhD, associate director of the Vanderbilt Vaccine Center in Tennessee.
Scientists use isolated B cells to recreate monoclonal antibodies in a laboratory. This can be mass produced and given to people through an IV.
A monoclonal antibody targets a specific antigen on a virus or bacteria. So this treatment differs from convalescent plasma, which contains multiple antibodies that target different antigens.
Most of the monoclonal antibodies being developed to treat COVID-19 target the spike protein, which the coronavirus (SARS-CoV-2) uses to enter the host cells.
...}

New Covid Variants: Symptoms May Show Up In This Order

The new COVID-19 subvariant "Eris" was the dominant strain in the United States in August 2023. By September, the new "Pirola" variant was detected in multiple countries. Understanding the difference between COVID-19 symptoms and flu symptoms can help ensure appropriate treatment.

www.healthline.com

They are just expensive and interfere with any natural recovery immunity.

 

[OKTexas]

No, monoclonal antibodies are the most successful means of treatment.
{...
According to the Food and Drug Administration (FDA)Trusted Source, this experimental treatment uses “laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses” like SARS-CoV-2.
It’s especially useful for people with weakened immune systems who may not generate a robust response to the COVID-19 vaccines, and for others at high risk of severe illness.
While monoclonal antibodies can start to clear the coronavirus within hours of being infused intravenously (IV) into the body, this treatment may not work for everyone.
That’s why experts recommend that people get fully vaccinated against COVID-19, which is known to prevent severe illness and hospitalization due to the disease.

How do monoclonal antibodies work?​

A monoclonal antibody is a laboratory-produced protein that functions like the antibodies made by the immune system in response to infection.
By binding to a specific molecule on a virus or bacteria — known as an antigen — a monoclonal antibody can enhance or restore the immune response against these pathogens.
Monoclonal antibody treatment has been used and testedTrusted Source for the Ebola virus and respiratory syncytial virus (RSV), as well as chronic illnesses such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and more.
Scientists are also developing monoclonal antibodies that target cancer cells.
Scientists sometimes develop monoclonal antibodies by isolating certain immune cells — called B cells — from a person who has successfully recovered from an infection.
With COVID-19, “we looked in people who had a good antibody response to the virus and picked out the very best antibodies that they made,” said Robert Carnahan, PhD, associate director of the Vanderbilt Vaccine Center in Tennessee.
Scientists use isolated B cells to recreate monoclonal antibodies in a laboratory. This can be mass produced and given to people through an IV.
A monoclonal antibody targets a specific antigen on a virus or bacteria. So this treatment differs from convalescent plasma, which contains multiple antibodies that target different antigens.
Most of the monoclonal antibodies being developed to treat COVID-19 target the spike protein, which the coronavirus (SARS-CoV-2) uses to enter the host cells.
...}

New Covid Variants: Symptoms May Show Up In This Order

The new COVID-19 subvariant "Eris" was the dominant strain in the United States in August 2023. By September, the new "Pirola" variant was detected in multiple countries. Understanding the difference between COVID-19 symptoms and flu symptoms can help ensure appropriate treatment.

www.healthline.com

They are just expensive and interfere with any natural recovery immunity.

Ugh, cough, cough.

FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the covid-19 treatments​

https://www.washingtonpost.com/health/2022/01/24/biden-administration-monoclonal-antibodies/

.